共 50 条
- [31] HIGH RATES OF ADHERENCE TO BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS DELTA THROUGH 96 WEEKS: RESULTS FROM AN INTERIM ANALYSIS OF THE PHASE 3 STUDY MYR301GASTROENTEROLOGY, 2024, 166 (05) : S1603 - S1604Aleman, SooWedemeyer, HeinerBrunetto, Maurizia R.Blank, AntjeAndreone, PietroBogomolov, PavelChulanov, VladimirMamonova, NinaGeyvandova, NataliaMorozov, ViacheslavSagalova, OlgaStepanova, Tatyana V.Da, BenManuilov, DmitryChee, GraceLi, MingyangLau, Audrey H.zur Wiesch, Julian SchulzeCornberg, MarkusZeuzem, StefanLampertico, Pietro
- [32] Efficacy and safety of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis delta at 96 weeks: Results from an interim analysis of a phase 3 randomized studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 101 - 102Wedemeyer, HeinerAleman, SooBrunetto, MauriziaBlank, AntjeAndreone, PietroBogomolov, PavelChulanov, VladimirMamonova, NinaGeyvandova, NataliaMorozov, ViacheslavSagalova, OlgaStepanova, TatyanaManuilov, DmitryMercier, Renee-ClaudeAn, QiFreismuth, AurelieFlaherty, John F.Osinusi, AnuLau, AudreyWiesch, Julian Schulze ZurCornberg, MarkusZeuzem, StefanLampertico, Pietro
- [33] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDYGUT, 2023, 72 : A103 - A104Wedemeyer, HeinerAleman, SooBrunetto, MauriziaBlank, AntjeAndreone, PietroBogomolov, PavelChulanov, VladimirMamonova, NinaGeyvandova, NataliaMorozov, ViacheslavSagalova, OlgaStepanova, TatyanaManuilov, DmitryMercier, Renee-ClaudeAn, QiFlaherty, JohnOsinusi, AnuLau, Audreyzur Wiesch, Julian SchulzeCornberg, MarkusZeuzem, StefanLampertico, Pietro
- [34] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results from the phase 3 DELTA-1 and-2 studiesALLERGOLOGIE, 2024, 47 (09)Bissonnette, R.Worm, M.Warren, R. B.Agner, T.Gooderham, M.Schuttelaar, M. L.Baranowski, K.Plohberger, U.Soerensen, L.Schliemann, S.
- [35] The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48-week randomized phase 4 study: STAR studyACTA OPHTHALMOLOGICA, 2023, 101 (03) : E327 - E337Li, XiaoxinQu, JinfengSu, GuanfangYu, SuqinZhang, YongjinSadda, Srini Vas
- [36] A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 studyJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S33 - S34Yurdaydin, C.Idilman, R.Keskin, O.Kalkan, C.Karakaya, M. F.Caliskan, A.Yurdcu, E.Karatayli, S. C.Bozdayi, M.Koh, C.Heller, T.Glenn, J.
- [37] Achieving equity for all cancer patients - A prospective study of representation of LGBTQIA plus patients on early phase cancer clinical trials: results from a PEARLER sub-studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 165 - 165Nguyen, Rebecca H.Nindra, UditTeng, ChristinaWei, JoeKillen, AndrewCooper, AdamWilkinson, KateRoohullah, AflahLemech, CharlotteChua, WeiAbhijit, P. A. L.
- [38] A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis - end of study results from the LOWR HDV-3 studyJOURNAL OF HEPATOLOGY, 2017, 66 (01) : S101 - S102Koh, C.Surana, P.Han, T.Fryzek, N.Kapuria, D.Etzion, O.Takyar, V.Rotman, Y.Canales, R.Dahari, H.Yurdaydin, C.Glenn, J.Heller, T.
- [39] Efficacy and safety of tenalisib, a PI3K delta/gamma and SIK3 inhibitor in patients with locally advanced or metastatic breast cancer: Results from a phase II studyANNALS OF ONCOLOGY, 2022, 33 (07) : S640 - S640Makharadze, T.Kiladze, I. Z.Dzagnidze, G.Semionova-Peskova, N.Katselashvili, L.Vekua, N.Routhu, K.Barde, P.Nair, A.
- [40] Efficacy and safety of BLV monotherapy for chronic hepatitis delta: posttreatment results through 48 weeks after the end of treatment from an interim analysis of a randomised Phase 3 study MYR301DIGESTIVE AND LIVER DISEASE, 2025, 57Aleman, S.Brunetto, M.Blank, A.Andreone, P.Bogomolov, P.Chulanov, V.Mamonova, N.Geyvandova, N.Morozov, V.Sagalova, O.Stepanova, T.Chee, G. M.Mercier, R. C.Lichtman, A.Manuilov, D.Arterburn, S.Lau, A. H.Osinusi, A.Christian-Cox, Flo.Duff, F.zur Wiesch, J. SchulzeCornberg, M.Zeuzem, S.Wedemeyer, H.Lampertico, P.